Premium Nahrungsergänzungsmittel | artgerecht

Bladder Motility – Function, Disorders and Treatment

Bladder motility refers to the ability of the urinary bladder to fill and empty in a controlled manner through muscle activity. Disorders can cause incontinence or urinary retention.

Regular tips about health Regular tips about health

Things worth knowing about "Bladder Motility"

Bladder motility refers to the ability of the urinary bladder to fill and empty in a controlled manner through muscle activity. Disorders can cause incontinence or urinary retention.

What Is Bladder Motility?

Bladder motility refers to the motor function of the urinary bladder -- its ability to store and controllably release urine through coordinated muscular activity. The bladder wall contains a specialized smooth muscle layer known as the detrusor muscle. The coordinated interaction between this muscle, the bladder neck, and the urethral sphincters enables normal bladder function.

Bladder motility is regulated by the autonomic nervous system and by voluntary nerve signals from the central nervous system. Intact bladder motility is essential for urinary continence and comfortable urination (micturition).

Physiology of Bladder Function

Bladder function can be divided into two phases:

Filling phase: The detrusor muscle remains relaxed while the sphincter stays contracted, allowing the bladder to store urine without triggering involuntary urge.
Voiding phase (micturition): The detrusor contracts in a coordinated manner, the sphincter relaxes, and urine is expelled.

This process is controlled by nerve centers in the sacral spinal cord, the brainstem (pontine micturition center), and the prefrontal cortex.

Disorders of Bladder Motility

Disorders of bladder motility can be classified into two main categories:

Overactive Bladder (OAB)

In an overactive bladder, the detrusor muscle contracts involuntarily, leading to urgency, frequent urination (urinary frequency), and possibly urge incontinence. Causes may include neurological conditions, urinary tract infections, or idiopathic factors.

Underactive Bladder (UAB)

An underactive bladder is characterized by reduced detrusor contractility, leading to incomplete bladder emptying, post-void residual urine, and in severe cases, urinary retention. Common causes include diabetic neuropathy, spinal cord injuries, and pelvic floor dysfunction.

Causes of Bladder Motility Disorders

Neurological conditions (e.g., multiple sclerosis, Parkinson disease, stroke, spinal cord injury)
Diabetes mellitus (diabetic bladder neuropathy)
Benign prostatic hyperplasia in men
Pelvic floor weakness, e.g., following childbirth or with aging
Urinary tract infections and inflammation
Medication side effects (e.g., anticholinergics, opioids)
Congenital conditions (e.g., spina bifida)

Symptoms

Frequent urination (urinary frequency)
Sudden, urgent need to urinate (urinary urgency)
Involuntary urine loss (incontinence)
Weak urine stream or interrupted voiding
Sensation of incomplete bladder emptying
Pain or burning during urination

Diagnosis

Several diagnostic methods are used to evaluate bladder motility:

Urodynamics: The gold standard for measuring bladder pressure, detrusor contractions, and urine flow. It allows precise characterization of filling and voiding disorders.
Uroflowmetry: Non-invasive measurement of urine flow rate and voiding time.
Post-void residual measurement: Ultrasound-based assessment of urine remaining in the bladder after voiding.
Cystoscopy: Direct visualization of the bladder mucosa using an endoscope.
Imaging: Ultrasound, MRI, or X-ray to assess anatomical structures.
Neurological examination: When a neurogenic cause is suspected.

Treatment

Treatment of bladder motility disorders depends on the underlying cause and severity:

Conservative Measures

Bladder training and voiding diary
Pelvic floor exercises (physiotherapy)
Adjustment of fluid intake and diet

Pharmacological Therapy

Anticholinergics / antimuscarinics (e.g., oxybutynin, solifenacin) for overactive bladder
Beta-3 adrenoceptor agonists (e.g., mirabegron) to relax the detrusor muscle
Alpha-blockers (e.g., tamsulosin) for bladder outlet obstruction
Cholinergic agents to enhance detrusor contractility in underactive bladder

Interventional and Surgical Therapy

Botulinum toxin injections into the detrusor muscle for refractory overactive bladder
Sacral neuromodulation (electrical stimulation of the sacral nerves)
Surgical procedures, e.g., for prostatic enlargement or anatomical abnormalities
Intermittent self-catheterization for chronic urinary retention

References

Abrams P et al. - The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-178.
Wein AJ, Kavoussi LR et al. (eds.) - Campbell-Walsh Urology. 12th edition. Elsevier. 2021.
Nambiar AK et al. - EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. European Urology. 2018;73(4):596-609.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category